NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice
Top Cited Papers
- 21 April 2003
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 9 (5) , 596-603
- https://doi.org/10.1038/nm867
Abstract
To explore induced islet neogenesis in the liver as a strategy for the treatment of diabetes, we used helper-dependent adenovirus (HDAD) to deliver the pancreatic duodenal homeobox-1 gene (Ipf1; also known as Pdx-1) to streptozotocin (STZ)-treated diabetic mice. HDAD is relatively nontoxic as it is devoid of genes encoding viral protein. Mice treated with HDAD-Ipf1 developed fulminant hepatitis, however, because of the exocrine-differentiating activity of Ipf1. The diabetes of STZ mice was partially reversed by HDAD-mediated transfer of NeuroD (Neurod), a factor downstream of Ipf1, and completely reversed by a combination of Neurod and betacellulin (Btc), without producing hepatitis. Treated mice were healthy and normoglycemic for the duration of the experiment (>120 d). We detected in the liver insulin and other islet-specific transcripts, including proinsulin-processing enzymes, β-cell–specific glucokinase and sulfonylurea receptor. Immunocytochemistry detected the presence of insulin, glucagon, pancreatic polypeptide and somatostatin-producing cells organized into islet clusters; immuno-electron microscopy showed typical insulin-containing granules. Our data suggest that Neurod-Btc gene therapy is a promising regimen to induce islet neogenesis for the treatment of insulin-dependent diabetes.Keywords
This publication has 31 references indexed in Scilit:
- Constitutive and regulated expression of processed insulin following in vivo hepatic gene transferGene Therapy, 2002
- Recent advances in insulin gene therapy for type 1 diabetesTrends in Molecular Medicine, 2002
- The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identityThe Journal of cell biology, 2001
- The canals of hering and hepatic stem cells in humansHepatology, 1999
- High-Capacity Adenoviral Vectors for Gene Transfer and Somatic Gene TherapyHuman Gene Therapy, 1999
- High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels ofα1-Antitrypsin with Negligible ToxicityHuman Gene Therapy, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressingα1-Antitrypsin after Systemic DeliveryHuman Gene Therapy, 1998
- Betacellulin: a mitogen from pancreatic beta cell tumorsScience, 1993
- A suppressive role of c‐kinase for the stimulation of hepatic ketogenesis by glucagon and epinephrineFEBS Letters, 1986